Freestone Capital Holdings, LLC Eli Lilly & CO Transaction History

Freestone Capital Holdings, LLC

$2.9 Billion
Q3 2024

A detailed history of Freestone Capital Holdings, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Freestone Capital Holdings, LLC holds 26,754 shares of LLY stock, worth $21 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares

26,754

Previous 26,565 0.71%

Holding current value

$21 Million

Previous $24.1 Million 1.45%

% of portfolio

0.82%

Previous 0.86%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $145,934 - $181,443	189 Added 0.71%	26,754 $23.7 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $164,545 - $206,352	227 Added 0.86%	26,565 $24.1 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $906,658 - $1.21 Million	1,531 Added 6.17%	26,338 $20.5 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $230,558 - $271,798	439 Added 1.8%	24,807 $14.5 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $139,538 - $192,375	-321 Reduced 1.3%	24,368 $13.1 Million
Q2 2023 Aug 09, 2023	BUY	$350.74 - $468.98 $274,629 - $367,211	783 Added 3.28%	24,689 $11.6 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $661,641 - $777,066	-2,130 Reduced 8.18%	23,906 $8.21 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $387,467 - $451,477	-1,205 Reduced 4.42%	26,036 $9.53 Million
Q3 2022 Nov 09, 2022	SELL	$296.48 - $337.87 $1.44 Million - $1.64 Million	-4,857 Reduced 15.13%	27,241 $8.81 Million
Q2 2022 Aug 09, 2022	SELL	$278.73 - $327.27 $857,094 - $1.01 Million	-3,075 Reduced 8.74%	32,098 $10.4 Million
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $137,997 - $171,496	588 Added 1.7%	35,173 $10.1 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $305,796 - $379,494	1,360 Added 4.09%	34,585 $9.55 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $5,540 - $6,817	-25 Reduced 0.08%	33,225 $7.68 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $1.34 Million - $1.73 Million	7,427 Added 28.76%	33,250 $7.63 Million
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $32,206 - $41,693	196 Added 0.76%	25,823 $4.82 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $2.97 Million - $3.94 Million	-22,797 Reduced 47.08%	25,627 $4.33 Billion
Q3 2020 Nov 06, 2020	SELL	$146.22 - $169.13 $106,594 - $123,295	-729 Reduced 1.48%	48,424 $7.17 Million
Q2 2020 Aug 04, 2020	BUY	$136.42 - $164.18 $3.75 Million - $4.51 Million	27,480 Added 126.79%	49,153 $8.07 Million
Q1 2020 May 12, 2020	SELL	$119.05 - $147.35 $147,741 - $182,861	-1,241 Reduced 5.42%	21,673 $3.01 Million
Q4 2019 Feb 04, 2020	BUY	$106.92 - $132.43 $58,806 - $72,836	550 Added 2.46%	22,914 $3.01 Million
Q3 2019 Nov 07, 2019	SELL	$106.79 - $116.16 $1,281 - $1,393	-12 Reduced 0.05%	22,364 $2.5 Million
Q2 2019 Aug 05, 2019	BUY	$110.79 - $129.32 $122,422 - $142,898	1,105 Added 5.19%	22,376 $2.48 Million
Q1 2019 May 08, 2019	SELL	$111.31 - $131.02 $232,526 - $273,700	-2,089 Reduced 8.94%	21,271 $2.76 Million
Q4 2018 Feb 12, 2019	SELL	$105.9 - $118.64 $268,668 - $300,989	-2,537 Reduced 9.8%	23,360 $2.7 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $144,759 - $180,924	-1,686 Reduced 6.11%	25,897 $2.78 Million
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $20,211 - $23,196	267 Added 0.98%	27,583 $2.35 Million
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $66,863 - $78,927	901 Added 3.41%	27,316 $2.11 Million
Q4 2017 Feb 13, 2018	BUY	$81.94 - $87.89 $50,638 - $54,316	618 Added 2.4%	26,415 $2.23 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $20,192 - $22,411	262 Added 1.03%	25,797 $2.21 Million
Q2 2017 Aug 15, 2017	BUY	N/A	25,535	25,535 $2.1 Million

Others Institutions Holding LLY

# of Institutions

3,994

Shares Held

752M

Call Options Held

7.31M

Put Options Held

9.23M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $747B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Freestone Capital Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Freestone Capital Holdings, LLC with notifications on news.

Account

Freestone Capital Holdings, LLC Eli Lilly & CO Transaction History